Celularity (CELU) Other Working Capital Changes (2020 - 2025)
Celularity (CELU) posted quarterly Other Working Capital Changes of $1.1 million for Q4 2025, up 1233.72% year-over-year from $86000.0 in Q4 2024, and up 218.74% quarter-over-quarter from -$966000.0 in Q3 2025.
Celularity (CELU) Other Working Capital Changes (2020 - 2025) Analysis & Trends
Celularity (CELU) has reported Other Working Capital Changes for 6 consecutive years, with $1.1 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Other Working Capital Changes rose 1233.72% year-over-year to $1.1 million; the TTM figure through Dec 2025 stood at $350000.0 (down 5.66% YoY), while the FY2025 annual figure was $350000.0, down 5.66% from the prior year.
- Other Working Capital Changes rose to $1.1 million in Q4 2025 per CELU's latest filing, from -$966000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $1.1 million in Q2 2021 and bottomed at -$9.9 million in Q4 2021.
- Historically, Other Working Capital Changes has averaged -$745100.0 across 5 years, with a median of -$256000.0 in 2025.
- Annual changes were most pronounced in 2021 — Other Working Capital Changes soared 5510.81% — and 2025, when it tumbled 1011.32%.
- Celularity's Other Working Capital Changes stood at $6.0 million in 2021, then tumbled by 104.28% to -$257000.0 in 2022, then plunged by 734.63% to -$2.1 million in 2023, then soared by 104.01% to $86000.0 in 2024, then jumped by 1233.72% to $1.1 million in 2025.
- Business Quant data shows CELU's Other Working Capital Changes at $1.1 million in Q4 2025, -$966000.0 in Q3 2025, and $86000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.99 Bn | 132.14 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.80 Bn | 78.80 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.38 Bn | 60.19 Bn | 1.37 Bn |
| 4 | Moderna | 60.70 Bn | 55.56 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.22 Bn | 37.12 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.45 Bn | 10.06 Bn | 668.28 Mn |
| 8 | Insmed | 27.47 Bn | 26.31 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.21 Bn | 26.37 Bn | - |
| 10 | Celularity | 21.75 Mn | 15.58 Mn | -3.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -261,000.00 |
| Dec 31, 2025 | -261,000.00 |
| Dec 31, 2025 | -261,000.00 |
| Sep 30, 2025 | 348,000.00 |
| Sep 30, 2025 | 348,000.00 |
| Sep 30, 2025 | 348,000.00 |
| Jun 30, 2025 | 204,000.00 |
| Jun 30, 2025 | 204,000.00 |
| Jun 30, 2025 | 204,000.00 |
| Mar 31, 2025 | -251,000.00 |
| Mar 31, 2025 | -251,000.00 |
| Mar 31, 2025 | -251,000.00 |
| Dec 31, 2024 | -796,000.00 |
| Dec 31, 2024 | -796,000.00 |
| Dec 31, 2024 | -796,000.00 |
| Sep 30, 2024 | 741,000.00 |
| Sep 30, 2024 | 741,000.00 |
| Sep 30, 2024 | 741,000.00 |
| Jun 30, 2024 | -556,000.00 |
| Jun 30, 2024 | -556,000.00 |